Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-03-15 07:57 am Purchase | 13G | Satsuma Pharmaceuticals Inc. STSA | COMMODORE CAPITAL LP | 2,119,245 6.7% | 2,119,245 (New Position) | View |
| 2021-03-02 4:32 pm Purchase | 13D | Satsuma Pharmaceuticals Inc. STSA | RA CAPITAL MANAGEMENT L.P. | 5,914,252 18.8% | 1,232,394 (+26.32%) | View |
| 2021-02-16 4:30 pm Sale | 13G | Satsuma Pharmaceuticals Inc. STSA | CITADEL ADVISORS LLC | 364,785 2.1% | -652,697 (-64.15%) | View |
| 2021-02-12 3:59 pm Purchase | 13G | Satsuma Pharmaceuticals Inc. STSA | MORGAN STANLEY MS | 993,623 5.7% | 112,185 (+12.73%) | View |
| 2020-12-18 4:27 pm Purchase | 13G | Satsuma Pharmaceuticals Inc. STSA | MORGAN STANLEY MS | 881,438 5.1% | 881,438 (New Position) | View |
| 2020-12-04 5:12 pm Sale | 13G | Satsuma Pharmaceuticals Inc. STSA | Osage University Partners III LP | 0 0% | -935,058 (Position Closed) | View |
| 2020-10-09 1:53 pm Sale | 13G | Satsuma Pharmaceuticals Inc. STSA | WELLINGTON MANAGEMENT GROUP LLP | 0 0% | -1,343,168 (Position Closed) | View |
| 2020-08-10 09:43 am Sale | 13G | Satsuma Pharmaceuticals Inc. STSA | WELLINGTON MANAGEMENT GROUP LLP | 1,343,168 7.72% | -998,043 (-42.63%) | View |
| 2020-02-14 4:07 pm Purchase | 13G | Satsuma Pharmaceuticals Inc. STSA | CITADEL ADVISORS LLC | 1,017,482 5.9% | 58,881 (+6.14%) | View |
| 2020-02-14 1:46 pm Sale | 13G | Satsuma Pharmaceuticals Inc. STSA | CAXTON CORP | 659,252 3.8% | -211,568 (-24.30%) | View |
| 2020-02-13 4:11 pm Purchase | 13G | Satsuma Pharmaceuticals Inc. STSA | TPG Group Holdings (SBS) Advisors Inc. | 1,885,939 10.6% | 1,885,939 (New Position) | View |
| 2020-01-27 3:56 pm Sale | 13G | Satsuma Pharmaceuticals Inc. STSA | WELLINGTON MANAGEMENT GROUP LLP | 2,341,211 13.47% | -64,084 (-2.66%) | View |
| 2019-11-27 4:55 pm Purchase | 13G | Satsuma Pharmaceuticals Inc. STSA | Osage University Partners III LP | 935,058 5.4% | 935,058 (New Position) | View |
| 2019-10-21 12:51 pm Purchase | 13G | Satsuma Pharmaceuticals Inc. STSA | CAXTON CORP | 870,820 5.1% | 870,820 (New Position) | View |
| 2019-10-10 10:45 am Purchase | 13G | Satsuma Pharmaceuticals Inc. STSA | WELLINGTON MANAGEMENT GROUP LLP | 2,405,295 13.58% | 2,405,295 (New Position) | View |
| 2019-09-23 08:48 am Purchase | 13G | Satsuma Pharmaceuticals Inc. STSA | CITADEL ADVISORS LLC | 958,601 5.8% | 958,601 (New Position) | View |
| 2019-09-17 4:54 pm Purchase | 13D | Satsuma Pharmaceuticals Inc. STSA | RA CAPITAL MANAGEMENT L.P. | 4,681,858 28.2% | 4,681,858 (New Position) | View |